Browsing by Author Morrish, Alicia

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)Citation
2016The effect of pentoxifylline on oxidative stress in chronic kidney disease patients with erythropoiesis-stimulating agent hyporesponsiveness: Sub-study of the HERO trialPerkovic, Vlado; Badve, Sunil; Cass, Alan; Clarke, Philip M; Coombes, Jeff; Dalziel, Kim; et al, Various; Ferrari, Paolo; McDonald, Stephen; Morrish, Alicia; Pascoe, Elaine; Pedagogos, Eugenie; Zhang, Lei; The George Institute for Global HealthThe effect of pentoxifylline on oxidative stress in chronic kidney disease patients with erythropoiesis-stimulating agent hyporesponsiveness: Sub-study of the HERO trial, Redox Report, vol.21, 1, 2016,pp 14-23
2014Establishing a clinical trials network in nephrology: Experience of the Australasian Kidney Trials NetworkPerkovic, Vlado; Badve, Sunil V.; Cass, Alan; Hawley, Carmel; Johnson, David; Morrish, Alicia; Reidlinger, Donna; The George Institute for Global HealthEstablishing a clinical trials network in nephrology: Experience of the Australasian Kidney Trials Network, Kidney International, vol.85, 1, 2014,pp 23-30
2015A Randomized, Placebo-Controlled Trial of Pentoxifylline on Erythropoiesis-Stimulating Agent Hyporesponsiveness in Anemic Patients With CKD: The Handling Erythropoietin Resistance With Oxpentifylline (HERO) TrialPerkovic, Vlado; Badve, Sunil V.; Cass, Alan; Clarke, Philip M; Dalziel, Kim; et al, Various; Ferrari, Paolo; Johnson, David W; McDonald, S; Morrish, Alicia; Pascoe, Elaine; Pedagogos, Eugenie; The George Institute for Global HealthA Randomized, Placebo-Controlled Trial of Pentoxifylline on Erythropoiesis-Stimulating Agent Hyporesponsiveness in Anemic Patients With CKD: The Handling Erythropoietin Resistance With Oxpentifylline (HERO) Trial, American Journal of Kidney Diseases, vol.65, 1, 2015,pp 49-57